These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2115038)

  • 1. Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones.
    Schlaeffer F; Blaser J; Laxon J; Zinner S
    J Antimicrob Chemother; 1990 Jun; 25(6):941-8. PubMed ID: 2115038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
    Feng P; Yu R; Xia P; Lü X; Zhu S
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms.
    Sonstein SA; Burnham JC
    Diagn Microbiol Infect Dis; 1993; 16(4):277-89. PubMed ID: 8388327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
    Pruul H; McDonald PJ
    J Antimicrob Chemother; 1990 Jan; 25(1):91-101. PubMed ID: 2108116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on antagonistic effects of low pH and cation supplementation on in-vitro activity of quinolones and aminoglycosides against Pseudomonas aeruginosa.
    Blaser J; Lüthy R
    J Antimicrob Chemother; 1988 Jul; 22(1):15-22. PubMed ID: 3139613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibacterial activity of cefpirome in combination with 4 aminoglycosides and 2 fluoroquinolones].
    Le Noc P; Croize J; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):762-7. PubMed ID: 3141888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
    Blaser J; Stone BB; Groner MC; Zinner SH
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
    Mayer I; Nagy E
    APMIS; 2000 Apr; 108(4):261-6. PubMed ID: 10843412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of clinically important resistance to quinolones and other antibiotic groups.
    Lode H
    J Int Med Res; 1990; 18 Suppl 4():27D-36D. PubMed ID: 2282967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM; Lee GC; Ellis ME
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.
    Rådberg G; Nilsson LE; Svensson S
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2142-7. PubMed ID: 2127345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quinolones against slowly growing bacteria.
    Dalhoff A; Matutat S; Ullmann U
    Chemotherapy; 1995; 41(2):92-9. PubMed ID: 7758362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequencies of subpopulations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis.
    Rådberg G; Nilsson LE; Kihlström E; Maller R; Sörén L
    J Antimicrob Chemother; 1992 Oct; 30(4):489-96. PubMed ID: 1490921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of fluoroquinolones with other antimicrobial agents.
    Neu HC
    Rev Infect Dis; 1989; 11 Suppl 5():S1025-35. PubMed ID: 2505355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.
    Asuquo AE; Piddock LJ
    J Antimicrob Chemother; 1993 Jun; 31(6):865-80. PubMed ID: 8360125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.